Global Brand Lead, Epilepsy — Launch

Il y a 5 jours

Brussel, Brussel-Hoofdstad, Belgique UCB Temps plein 180 000 € - 240 000 €/an

UCB, a global biopharmaceutical company, seeks a Global Brand Head Epilepsy Brands to maximize the value of BRIVIACT, VIMPAT, KEPPRA and NAYZILAM. You will shape robust commercial strategies, drive lifecycle and launch excellence, and translate insights into strategic decisions to support sustainable growth in epilepsy care.

You will collaborate across Commercial, Medical, Market Access, Supply, Regulatory, HEOR and Insights, driving alignment and execution.